U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.9939_9942del (p.Lys3315fs) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 28, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000480739.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.9939_9942del (p.Lys3315fs)]

NM_000059.4(BRCA2):c.9939_9942del (p.Lys3315fs)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.9939_9942del (p.Lys3315fs)
HGVS:
  • NC_000013.11:g.32398452_32398455del
  • NG_012772.3:g.87973_87976del
  • NM_000059.4:c.9939_9942delMANE SELECT
  • NP_000050.3:p.Lys3315fs
  • LRG_293:g.87973_87976del
  • NC_000013.10:g.32972589_32972592del
  • NM_000059.3:c.9939_9942delGAAA
Protein change:
K3315fs
Links:
dbSNP: rs1064793547
NCBI 1000 Genomes Browser:
rs1064793547
Molecular consequence:
  • NM_000059.4:c.9939_9942del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000566389GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Apr 28, 2015)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000566389.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This deletion of 4 nucleotides in BRCA2 is denoted c.9939_9942delGAAA at the cDNA level and p.Lys3315AsnfsX2 (K3315NfsX2) at the protein level. The normal sequence, with the bases that are deleted in braces, is TAAA[GAAA]AAAG. The deletion causes a frameshift, which changes a Lysine to an Asparagine at codon 3315, and creates a premature stop codon at position 2 of the new reading frame. This variant has not, to our knowledge, been reported in the literature as pathogenic or benign. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Although this variant results in a frameshift and premature stop codon, it is located just upstream of a well-known polymorphism that also results in a premature stop of translation (K3326X), suggesting that this region of the BRCA2 gene and the region beyond codon 3326 is not crucial for proper function. Based on currently available information, it is unclear whether this deletion is pathogenic or benign. We consider it to be a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024